Oridonin, a Promising ent-Kaurane Diterpenoid Lead Compound
AbstractOridonin belongs to ent-kaurane tetracyclic diterpenoid and was first isolated from Isodon species. It exhibits inhibitory activities against a variety of tumor cells, and pharmacological study shows that oridonin could inhibit cell proliferation, DNA, RNA and protein synthesis of cancer cells, induce apoptosis and exhibit an antimutagenic effect. In addition, the large amount of the commercially-available supply is also very important for the natural lead oridonin. Moreover, the good stability, suitable molecular weight and drug-like property guarantee its further generation of a natural-like compound library. Oridonin has become the hot molecule in recent years, and from the year 2010, more than 200 publications can be found. In this review, we summarize the synthetic medicinal chemistry work of oridonin from the first publication 40 years ago and share our research experience of oridonin for about 10 years, which may provide useful information to those who are interested in this research field. View Full-Text
Share & Cite This Article
Li, D.; Han, T.; Liao, J.; Hu, X.; Xu, S.; Tian, K.; Gu, X.; Cheng, K.; Li, Z.; Hua, H.; Xu, J. Oridonin, a Promising ent-Kaurane Diterpenoid Lead Compound. Int. J. Mol. Sci. 2016, 17, 1395.
Li D, Han T, Liao J, Hu X, Xu S, Tian K, Gu X, Cheng K, Li Z, Hua H, Xu J. Oridonin, a Promising ent-Kaurane Diterpenoid Lead Compound. International Journal of Molecular Sciences. 2016; 17(9):1395.Chicago/Turabian Style
Li, Dahong; Han, Tong; Liao, Jie; Hu, Xu; Xu, Shengtao; Tian, Kangtao; Gu, Xiaoke; Cheng, Keguang; Li, Zhanlin; Hua, Huiming; Xu, Jinyi. 2016. "Oridonin, a Promising ent-Kaurane Diterpenoid Lead Compound." Int. J. Mol. Sci. 17, no. 9: 1395.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.